Xylem Inc. $XYL Shares Sold by Dnca Finance

Dnca Finance decreased its stake in shares of Xylem Inc. (NYSE:XYL) by 8.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 87,500 shares of the industrial products company’s stock after selling 8,500 shares during the quarter. Dnca Finance’s holdings in Xylem were worth $11,319,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in XYL. Vanguard Group Inc. lifted its position in Xylem by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 29,697,829 shares of the industrial products company’s stock worth $3,841,711,000 after acquiring an additional 691,285 shares during the period. Geode Capital Management LLC raised its stake in shares of Xylem by 2.3% in the second quarter. Geode Capital Management LLC now owns 6,141,231 shares of the industrial products company’s stock worth $791,029,000 after purchasing an additional 136,605 shares during the last quarter. Amundi boosted its position in Xylem by 17.0% in the second quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock valued at $730,717,000 after buying an additional 830,337 shares during the last quarter. Impax Asset Management Group plc increased its holdings in Xylem by 13.7% in the 2nd quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company’s stock worth $709,183,000 after buying an additional 663,191 shares during the period. Finally, Swedbank AB raised its position in Xylem by 13.9% during the 2nd quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after buying an additional 531,890 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Stock Performance

Shares of XYL stock opened at $139.01 on Friday. The company has a market capitalization of $33.85 billion, a P/E ratio of 35.74, a P/E/G ratio of 2.16 and a beta of 1.18. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $154.27. The business’s 50 day moving average is $145.86 and its two-hundred day moving average is $138.59. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The firm had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same quarter last year, the firm posted $1.11 EPS. The business’s revenue was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Analysts expect that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.2%. Xylem’s payout ratio is currently 41.13%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on XYL. Mizuho set a $160.00 price objective on shares of Xylem in a report on Wednesday, October 29th. Royal Bank Of Canada increased their price target on Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Weiss Ratings reissued a “buy (b)” rating on shares of Xylem in a report on Monday, December 1st. Barclays raised their target price on Xylem from $165.00 to $172.00 and gave the stock an “overweight” rating in a report on Wednesday, October 29th. Finally, Citigroup upped their price objective on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Eight analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $167.40.

Insider Activity

In other Xylem news, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the transaction, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of Xylem stock in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the completion of the sale, the executive vice president directly owned 31,250 shares in the company, valued at $4,770,000. This represents a 25.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.27% of the stock is owned by corporate insiders.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.